← Back to Analyst Consensus 
ELVN Buy
Enliven Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 1 reiterations from 3 firms
Next Earnings
Nov 18, 2026 (22 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 2, 2026 | Morgan Stanley | initiate | — → Overweight | — | 54% |
| Oct 1, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| Aug 18, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Aug 18, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Aug 18, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 6, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Aug 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 6, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Jul 21, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Jul 9, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 1, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jun 29, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Jun 9, 2026 | Stifel | initiate | — → Buy | — | 53% |
| Jun 2, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 8, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Mar 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 25, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $48 | 44% |
| Jun 16, 2025 | Goldman Sachs | initiate | — → Buy | $37 | 54% |
| Jun 16, 2025 | Baird | maintain | Outperform → Outperform | $52 | 55% |
| May 16, 2025 | Jones Trading | maintain | Buy → Buy | $27 | 50% |
| May 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Mar 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $39 | 44% |
| Dec 13, 2024 | BTIG | initiate | — → Buy | $42 | 52% |
| Nov 15, 2024 | Baird | maintain | Outperform → Outperform | $40 | 55% |
| Oct 31, 2024 | Jones Trading | initiate | — → Buy | $36 | 50% |
| Oct 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $37 | 44% |
| Sep 9, 2024 | HC Wainwright & Co. | initiate | — → Buy | $37 | 44% |
| Jun 11, 2024 | Baird | initiate | — → Outperform | $32 | 55% |
| Apr 9, 2024 | Mizuho | initiate | — → Buy | $34 | 52% |
| Mar 29, 2023 | Jefferies | initiate | — → Buy | $27 | 52% |
| Mar 3, 2023 | TD Cowen | initiate | — → Outperform | $0 | 54% |
Price Target Trend
Jun 5, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days